high for Jordan

affordable for Jordan

Need a value for acceptance or rejection

BMI vary between both countries

dietry risk for glucose control

age and duration of DM might differ too

all of the above

Japan and Jordan run a universal health system-cost are valued in the same way

the cost of complications is beared diffrently in both countries- Jordan is fragmented and Prices subsided highly

Risk vary between both countries

Risk are similar across countries- effectivness measures applicable to Jordan

I need local data on both costs and outcome from Jordan

I agree with the study value for 1 year and thus I recomend the treatment change

cost of treatment and complications in Jordan are lower then Japan potentially the MIT is cost-effective in Iraq

without ensuring effectiveness measures on local data, cost effectiveness can’t be decided.

Jordanians have a high risk for CVD and diabetes potentially the effectiveness measure are more significant in Jordan. Thus cost effectiveness result from Japan can be applied in Jordan